Instead of drug rebates, turn to drugs' average sales prices - STAT

Instead of drug rebates, turn to drugs' average sales prices - STAT

Instead of eliminating drug rebates, use average sales price to set co-insurance levels

By ANDREW PARECE AND MATTHEW MAJEWSKI

ADOBE

The Trump administration wants to stop rebates for Medicare Part D drugs. Here's a better idea: base patient co-insurance levels on the average sales price.

READ MORE